J 2024

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

LAHMER, Tobias, Jon SALMANTON-GARCIA, Francesco MARCHESI, Shaimaa EL-ASHWAH, Marcio NUCCI et. al.

Základní údaje

Originální název

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Autoři

LAHMER, Tobias, Jon SALMANTON-GARCIA, Francesco MARCHESI, Shaimaa EL-ASHWAH, Marcio NUCCI, Caroline BESSON, Federico ITRI, Ozren JAKSIC, Natasha COLOVIC, Barbora WEINBERGEROVÁ (203 Česká republika, domácí), Guldane Cengiz SEVAL, Tatjana ADZIC-VUKICEVIC, Tomas SZOTKOWSKI, Uluhan SILI, Michelina DARGENIO, van Praet JENS, van Doesum JAAP, Martin SCHOENLEIN, Zdenek RACIL, Pavel ZAK, Christian Bjorn POULSEN, Gabriele MAGLIANO, Moraima JIMENEZ, Valentina BONUOMO, Klara PIUKOVICS, Giulia DRAGONETTI, Fatih DEMIRKAN, Ola BLENNOW, Toni VALKOVIC, Da Silva Maria GOMES, Johan MAERTENS, Andreas GLENTHOJ, Noemi FERNANDEZ, Rui BERGANTIM, Luisa VERGA, Verena PETZER, Ali S OMRANI, Gustavo-Adolfo MENDEZ, Marina MACHADO, Marie-Pierre LEDOUX, Rebeca BAILEN, Rafael F DUARTE, Del Principe Maria ILARIA, Francesca FARINA, Sonia MARTIN-PEREZ, Julio DAVILA-VALLS, Monia MARCHETTI, Yavuz M BILGIN, Nicola S FRACCHIOLLA, Chiara CATTANEO, Ildefonso ESPIGADO, Raul CORDOBA, Graham P COLLINS, Jorge LABRADOR, Iker FALCES-ROMERO, Lucia PREZIOSO, Stef MEERS, Francesco PASSAMONTI, Caterina BUQUICCHIO, Alberto LOPEZ-GARCIA, Austin KULASEKARARAJ, Irati ORMAZABAL-VELEZ, Annarosa CUCCARO, Carolina GARCIA-VIDAL, Alessandro BUSCA, Milan NAVRATIL, de Jonge NICK, Monika M BIERNAT, Anna GUIDETTI, Ghaith ABU-ZEINAH, Michail SAMARKOS, Amalia ANASTASOPOULOU, de Ramon CRISTINA, Tomas Jose GONZALEZ-LOPEZ, Martin HOENIGL, Olimpia FINIZIO, Laszlo Imre PINCZES, Natasha ALI, Antonio VENA, Carlo TASCINI, Zlate STOJANOSKI, Maria MERELLI, Ziad EMARAH, Milena KOHN, Aleksandra BARAC, Milos MLADENOVIC, Bojana MISKOVIC, Osman ILHAN, Gokce Melis COLAK, Martin CERNAN, Stefanie K GRAEFE, Emanuele AMMATUNA, Michaela HANAKOVA, Benjamin VISEK, Alba CABIRTA, Anna NORDLANDER, Raquel Nunes RODRIGUES, Ditte Stampe HERSBY, Giovanni Paolo Maria ZAMBROTTA, Dominik WOLF, Lucia NUNEZ-MARTIN-BUITRAGO, Elena ARELLANO, Francesco Aiello TOMMASO, Ramon GARCIA-SANZ, Juergen PRATTES, Matthias EGGER, Alessandro LIMONGELLI, Martina BAVASTRO, Milche CVETANOSKI, Miriam DIBOS, Sebastian RASCH, Laman RAHIMLI, Oliver A CORNELY a Livio PAGANO

Vydání

Infection, HEIDELBERG, Springer, 2024, 0300-8126

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 7.500 v roce 2022

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1007/s15010-023-02169-7

UT WoS

001183232800001

Klíčová slova anglicky

COVID-19; haematological malignancies

Štítky

14110212, rivok

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 12. 7. 2024 13:45, Mgr. Tereza Miškechová

Anotace

V originále

The risk for a severe coronavirus disease 2019 (COVID-19) with need for an intensive care unit (ICU) admission in a non-immunocompromised vaccinated population dropped from 5% at the beginning of the pandemic to at least 0.2% and is still decreasing since the omicron strain dominates the COVID-19 pandemic [1]. Beyond the risk factors identified for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection like male sex, older age, and comorbidities such as cardiovascular disease, lung disease or obesity, patients with a history of malignancy, specifically patients with haematological malignancy, are prone to develop a complicated SARS-CoV-2 infection with need for ICU which is still associated with poorer clinical outcome. The circumstances of a widely heterogenous population with regards to the type of haematological malignancy, extent of disease, haematological malignancy treatment history, and baseline performance status are even more challenging in the environment of an ICU. Although, data referring to critically ill COVID-19 patients regarding treatment strategies and outcome are widely available, data referring to critically ill patients with haematological malignancy are scarce and underreported. The aim of this study is to analyze the epidemiology, risk factors and outcome of patients with haematological malignancy with need for an ICU setting using the data from the large-scale EPICOVIDEHA registry of the European Hematology Association—Scientific Working Group Infectious in Hematology (EHA-SWG).
Zobrazeno: 17. 11. 2024 11:50